|Roche boosted by trial success with blood cancer drug|
Roche got a big boost on Friday when a clinical trial testing its new blood cancer drug Gazyva proved successful, lifting prospects for a new medicine that will be pivotal as the Swiss company fights the threat of biosimilar competition. Roche said Gazyva proved significantly better than its older drug Rituxan at delaying the progression of disease in people with previously untreated follicular lymphoma. Clinical trials with the new drug are important in deciding how well the Swiss drugmaker is placed to fend off cheaper competition from so-called biosimilar copies of Rituxan, which are likely to hit the market in the next couple of years.
|Biotech Regeneron replaces Intel as sponsor of Science Talent Search|
By Ransdell Pierson NEW YORK (Reuters) - Biotechnology company Regeneron Pharmaceuticals Inc on Thursday became the title sponsor of the most prestigious U.S. science competition for high school students, taking the baton from chipmaker Intel Corp. Regeneron pledged $100 million to support the Science Talent Search and related programs through 2026, and doubled awards for the top 300 scientists and their schools, to $2,000 each. Regeneron's two top executives competed in the annual event during the 1970s and went on to build one of the world's biggest biotech companies, with cutting-edge drugs for fighting macular degeneration, cancer and cholesterol. The fast-growing biotech company will take over as named sponsor from Intel, whose chips were helping build the personal computer industry in 1998 when it took over as sponsor from Westinghouse.
|Financial crisis may have caused 500,000 cancer deaths worldwide: study|
The global financial crisis may have caused an additional 500,000 cancer deaths from 2008-2010, a new study said Thursday, with patients locked out of treatment because of unemployment and healthcare cuts. The figures were extrapolated from an observed rise in cancer deaths for every percentage increase in unemployment, and every drop in public healthcare spending. "From our analysis we estimate that the economic crisis was associated with over 260,000 excess cancer deaths in the OECD (34-member Organisation for Economic Cooperation and Development) alone, between 2008-2010," study author Mahiben Maruthappu of Imperial College London told AFP.
|Timberwolves G Ricky Rubio's mom dies at 56 of lung cancer|
|Appeals court affirms 45-year sentence for cancer doctor|
|Lung cancer patients at bigger cancer centers may have better outcomes|
|After skin cancer, sun protection is still spotty|
|Colorectal Cancer on the Rise in Adults Under 50|
|Tragically Hip to begin tour in July despite singer's cancer|
|PETA asks LSU to stop using captive tigers as mascots|
|Bionic suit helps dad fulfil dream of walking daughter down the aisle|
Four years ago Chris Palmer was left paralysed after a long battle with cancer, leaving him fearful he wouldn't be able to walk his daughter, Heather, down the aisle on her wedding day. However his dream to get her down aisle became a reality on May 21 when Palmer used a £90,000 ($131,000) robotic suit made by Rex Bionics to walk unaided on the special day. "It's wonderful I can do this — it's fulfilling something that dads do," he said. If London Tube lines were people, they would be pretty entertaining Chewbacca makes epic surprise school visit straight from the 'Star Wars' set Emilia Clarke is feeling victorious about that male nudity on 'Game of Thrones' Adorable wolf dog getting a belly rub is the best thing you'll see today
|The Avengers heed call to visit teen battling cancer|